These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6284172)

  • 1. In vivo and in vitro effects of tetrahydroisoquinolines and other alkaloids on rat pituitary function.
    Britton DR; Rivier C; Shier T; Bloom F; Vale W
    Biochem Pharmacol; 1982 Apr; 31(7):1205-11. PubMed ID: 6284172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrahydroisoquinolines (TIQs) do not act on opiate receptors in the guinea-pig ileum.
    North RA; Collins MA; Milner JD; Karras PJ; Koziol DJ
    Eur J Pharmacol; 1981 May; 71(4):489-93. PubMed ID: 6265242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interaction of simple tetrahydroisoquinolines with opiate and high-affinity dopamine (D3) receptors in the rat corpus striatum].
    Patsenko AA; Grinevich VP; Ostrovskiĭ IuM
    Farmakol Toksikol; 1987; 50(4):33-5. PubMed ID: 2822473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does beta-endorphin modulate basal and dopamine-inhibited prolactin release by an action at the anterior pituitary?
    Cheung CY
    Neuroendocrinology; 1984 Dec; 39(6):489-95. PubMed ID: 6096753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-opiate beta-endorphin fragments and dopamine-V. gamma-Type endorphins and prolactin secretion in rats.
    Lamberts SW; de Quijada M; Van Ree JM; De Wied D
    Neuropharmacology; 1982 Nov; 21(11):1129-35. PubMed ID: 6184642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic inhibition of pituitary beta-endorphin-like immunoreactivity secretion in the rat.
    Farah JM; Malcolm DS; Mueller GP
    Endocrinology; 1982 Feb; 110(2):657-9. PubMed ID: 6276143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dopaminergic drugs on hypothalamic and pituitary immunoreactive beta-endorphin concentrations in the rat.
    Locatelli V; Petraglia F; Penalva A; Panerai AE
    Life Sci; 1983 Oct; 33(17):1711-7. PubMed ID: 6314082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate receptor binding and analgesic effects of the tetrahydroisoquinolines salsolinol and tetrahydropapaveroline.
    Fertel RH; Greenwald JE; Schwarz R; Wong L; Bianchine J
    Res Commun Chem Pathol Pharmacol; 1980 Jan; 27(1):3-16. PubMed ID: 6244607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol and some tetrahydroisoquinolines alter the discharge of cortical and hippocampal neurons: relationship to endogenous opioids.
    Berger T; French ED; Siggins GR; Shier WT; Bloom FE
    Pharmacol Biochem Behav; 1982 Oct; 17(4):813-21. PubMed ID: 7178189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A convergent approach to the pharmacology of tetrahydroisoquinolines.
    Britton DR
    Prog Clin Biol Res; 1982; 90():321-6. PubMed ID: 6287494
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopaminergic mediation of beta-endorphin-induced prolactin secretion.
    Van Loon GR; De Souza EB; Shin SH
    Neuroendocrinology; 1980 Oct; 31(4):293-6. PubMed ID: 6252497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by lithium of dopamine receptors in rat prolactin release.
    Tanimoto K; Maeda K; Chihara K
    Brain Res; 1981 Nov; 223(2):335-42. PubMed ID: 6269703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
    Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
    Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic stimulation of prolactin release.
    Denef C; Manet D; Dewals R
    Nature; 1980 May; 285(5762):243-6. PubMed ID: 6154895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic treatment with haloperidol on serum prolactin, striatal opiate receptors and beta-endorphin content in rat brain and pituitary.
    Kato N; Shah KR; Friesen HG; Havlicek V
    Prog Neuropsychopharmacol; 1981; 5(5-6):549-52. PubMed ID: 6280225
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of yohimbine on rat prolactin secretion.
    Meltzer HY; Simonovic M; Gudelsky GA
    J Pharmacol Exp Ther; 1983 Jan; 224(1):21-7. PubMed ID: 6294278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of neuroleptic drugs on endogenous opioid peptides in the rat.
    Höllt V
    Mod Probl Pharmacopsychiatry; 1981; 17():1-18. PubMed ID: 6120450
    [No Abstract]   [Full Text] [Related]  

  • 19. beta-Endorphin alters dopamine uptake by the dopamine neurons of the hypothalamus and striatum.
    George SR; Van Loon GR
    Brain Res; 1982 Sep; 248(2):293-303. PubMed ID: 6291701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperprolactinemia decreases the luteinizing hormone-releasing hormone concentration in pituitary portal plasma: a possible role for beta-endorphin as a mediator.
    Sarkar DK; Yen SS
    Endocrinology; 1985 May; 116(5):2080-4. PubMed ID: 3157564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.